Pharmaeutical titan, Allergan, is acquiring Tobira Therapuetics in a deal that’s initially for $28.35 per share. According to a statement however from Allergan, the deal could grow far more expensive. Tobira is developing two drugs to treat NASH disease, a silent and often common liver disease. According to the Allergan statement, NASH is a buildup … Continue reading “Allergan (AGN) May Pay A Lot Of Money For This Company”
Biotech & Pharma
Biotech & Pharma
New Cancer Drug Gives Hope To Many
A small trial has given hope to cancer fighters, especially those with the deadly form…
September 8, 2016
Biotech & Pharma
Merck & Co.(MRK) Just Discontinued This Major Pipeline Drug
Merck & Co. Inc. made a big announcement over its osteoporosis pipeline drug, odanacatib. The…
September 5, 2016
Biotech & Pharma
Mylan (MYL) To Make Cheaper Version Of EpiPen
It seems like Mylan NV has been paying attention to all the backlash against it…
August 29, 2016
Biotech & Pharma
Mylan’s (MYL) Price Of Epi Pens Just Got Cut In Half
EpiPens cost a lot of money but Mylan Pharamceuticals, the company who manufactures them, just…
August 25, 2016
Biotech & Pharma
Pfizer (PFE) In Talks To Acquire This Major Company
Sources familiar with the situation have revealed on Sunday that Pfizer Inc. is in advanced…
August 22, 2016
Biotech & Pharma
Medivation (MDNV) Gets Interest From Major Pharma
Medivation shares soared higher on Wednesday when a report revealed that at least five pharmaceutical…
August 18, 2016
Biotech & Pharma
Why Is Valeant (VRX) Under Criminal Investigation?
According to sources that told the Wall Street Journal what they knew, Valeant Pharmaceuticals may…
August 10, 2016
Biotech & Pharma
Heron (HRTX) Gets Green Light From FDA
Heron Therapeutic Inc's long acting injection Sustol, to prevent chemotherapy induced nausea and vomiting had…
August 10, 2016
Biotech & Pharma
New Vaccine Could Help Cocaine Addicts
Cocaine is one hell of a drug and for the more than 2 million people…
August 9, 2016
Biotech & Pharma
MEI Pharma Just Landed A Huge Million Dollar Deal
MEI Pharma will be getting $20 million in near-term cash and potentially hundreds millions more…
August 8, 2016
Biotech & Pharma
Ionis Pharmaceuticals (IONS) Achieves Major Milestone
Ionis shares saw a big pop in pre market trading on Monday, rising 37% to…
August 1, 2016
Biotech & Pharma
Autism May Soon Be Detected As Early As This Age
Autism is never an easy diagnosis to hear for a parent, as it means their…
July 26, 2016
Biotech & Pharma
Why Would Monsanto Reject This Much Money?
U.S. seed giant Monsanto has declined Bayer AG's $64 billion acquisition offer and says it…
July 25, 2016